{
  "ticker": "JNJ",
  "target_date": "2025-11-25",
  "actual_date": "2025-11-25",
  "collected_at": "2025-12-08T12:34:39.556521",
  "price": {
    "open": 205.18,
    "high": 207.72,
    "low": 205.18,
    "close": 206.6699981689453,
    "volume": 10275300,
    "change_1d_pct": 0.94,
    "change_7d_pct": 6.15,
    "change_30d_pct": 8.98
  },
  "technicals": {
    "rsi_14": 98.24,
    "sma_20": 193.18,
    "sma_50": 188.28,
    "macd": 4.748,
    "macd_signal": 3.35,
    "macd_histogram": 1.398,
    "bb_upper": 208.15,
    "bb_lower": 178.2,
    "price_vs_sma20_pct": 6.98,
    "price_vs_sma50_pct": 9.77,
    "volume_ratio": 1.09
  },
  "fundamentals": {
    "market_cap": 488303886336,
    "pe_ratio": 19.563225,
    "forward_pe": 19.120283,
    "price_to_book": 6.151547,
    "price_to_sales": 5.299069,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.47,
    "pct_from_52w_low": 44.07
  },
  "macro": {
    "spy": {
      "price": 675.02,
      "change_1d_pct": 0.94,
      "change_7d_pct": 1.4
    },
    "vix": {
      "level": 18.56,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.0
    },
    "dollar_index": {
      "level": 99.66
    },
    "gold": {
      "price": 4139.2
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Johnson & Johnson (JNJ): Exploring Valuation Perspectives After Recent Share Price Momentum",
      "source": "Yahoo",
      "datetime": 1764112634,
      "summary": "Johnson & Johnson (JNJ) shares have edged higher over the past month, building on a steady run that has seen the stock advance 17% in the past 3 months. Investors are watching for what comes next as momentum builds. See our latest analysis for Johnson & Johnson. The share price momentum for Johnson ",
      "url": "https://finnhub.io/api/news?id=6e446314292659f151e6998595f37d7005a571a57307fe00c1cb1a9c58364d48"
    },
    {
      "headline": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi",
      "source": "Yahoo",
      "datetime": 1764097260,
      "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
      "url": "https://finnhub.io/api/news?id=58762239f9e3a404d6f59494acb6333f47cfb175f789b1bd360b1f9dbeee9a22"
    },
    {
      "headline": "Best Dividend Kings: November 2025",
      "source": "SeekingAlpha",
      "datetime": 1764081928,
      "summary": "Discover which Dividend Kings are outperforming the S&P 500, recent dividend growth trends, and undervalued picks with strong return potential. Click to read.",
      "url": "https://finnhub.io/api/news?id=3f7039d7eca10e1146e996160a33d8cff7916360c0b263b16c61d1d2298eb2a4"
    },
    {
      "headline": "J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?",
      "source": "Yahoo",
      "datetime": 1764073440,
      "summary": "J&J's 16.7% rise reflects stronger sales guidance, rapid pipeline advances and improving MedTech momentum amid a recovering sector.",
      "url": "https://finnhub.io/api/news?id=42ccd668993012cedf9961a5de78b1ccac4b109d2a8e69f66ad59467c5c6ace0"
    },
    {
      "headline": "Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment",
      "source": "Yahoo",
      "datetime": 1764070200,
      "summary": "The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.",
      "url": "https://finnhub.io/api/news?id=e60775d825bc07ed9061f399c101c0bc6997bad6a58e91a84a26d48f05888360"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-11-25",
      "description": "xslF345X05/ownership.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525296047/xslF345X05/ownership.xml"
    },
    {
      "form": "4",
      "date": "2025-11-14",
      "description": "xslF345X05/ownership.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525282669/xslF345X05/ownership.xml"
    },
    {
      "form": "13F-HR",
      "date": "2025-11-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000587/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-11-10",
      "description": "xslF345X05/ownership.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525274067/xslF345X05/ownership.xml"
    },
    {
      "form": "10-Q",
      "date": "2025-10-22",
      "description": "jnj-20250928.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/jnj-20250928.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}